There is no single best medication for arthritis because the right choice depends on which type you have, which joints are affected, and how severe your symptoms are. Osteoarthritis and rheumatoid arthritis, the two most common forms, require fundamentally different treatment strategies. For osteoarthritis, topical and oral anti-inflammatory drugs are the strongest-supported options. For rheumatoid arthritis, a class of drugs that slow disease progression, not just mask pain, forms the backbone of treatment.
Osteoarthritis: First-Line Options
Osteoarthritis is the most common form of arthritis worldwide and one of the top ten most disabling diseases. It involves the breakdown of cartilage in joints, most often the hands, knees, and hips. Current guidelines give their strongest endorsement to three pharmacological options: topical anti-inflammatory gels or creams (especially for knees), oral anti-inflammatory drugs like ibuprofen or naproxen, and steroid injections into the knee or hip.
What’s notable is that topical anti-inflammatories earn the same top-tier recommendation as oral versions. A meta-analysis of eight trials covering more than 2,000 patients found that topical and oral anti-inflammatory drugs are equally effective at reducing pain and improving physical function in osteoarthritis. That matters because topical versions deliver the drug locally, which means far less exposure for your stomach, kidneys, and heart. If your arthritis is in the knee or hand, a topical gel may give you the same relief with fewer risks.
Acetaminophen: A Weaker Option Than You’d Expect
Acetaminophen (Tylenol) has long been recommended as a gentle first step for arthritis pain, and it still receives a conditional recommendation in guidelines. But the evidence behind it is modest. Systematic reviews show that anti-inflammatory drugs are slightly more effective than acetaminophen for joint pain, particularly when the hip is involved. Acetaminophen doesn’t reduce inflammation at all; it only targets pain signals. For many people with osteoarthritis, where inflammation drives much of the discomfort, that’s a meaningful limitation.
That said, acetaminophen has a role for people who can’t tolerate anti-inflammatory drugs due to stomach problems, kidney disease, or cardiovascular risk. It’s a reasonable fallback, not a first choice.
NSAID Risks Worth Knowing
All oral anti-inflammatory drugs, whether traditional or newer selective versions, increase the risk of cardiovascular events like heart attacks and strokes. This happens with both short-term and long-term use. These drugs can also raise blood pressure, reduce blood flow to the kidneys, cause fluid retention, and worsen heart failure. The standard guidance is to use the lowest effective dose for the shortest time possible and to avoid them entirely if you have established heart disease or significant risk factors.
This is one reason topical formulations are so valuable for localized joint pain. They deliver a fraction of the systemic dose while matching the pain relief of pills.
Steroid Injections for Flare-Ups
Corticosteroid injections directly into an arthritic joint can provide rapid, targeted relief during flare-ups. They’re strongly recommended for knee and hip osteoarthritis and conditionally recommended for hand joints. There’s no formal lifetime limit on the number of injections you can receive, but most doctors set a practical ceiling of three to four per year for any single joint. Repeated injections can weaken cartilage and surrounding tissue over time, so they work best as an occasional tool rather than a standing treatment plan.
Supplements: What the Evidence Actually Shows
Glucosamine and chondroitin are among the most popular supplements for joint pain, but the data on the classic combination is underwhelming. A network meta-analysis of 30 trials covering over 5,200 patients concluded that glucosamine plus chondroitin does not produce clinically meaningful pain reduction in people with mild-to-moderate knee osteoarthritis.
Some combinations fared better. Glucosamine paired with omega-3 fatty acids showed the largest and most durable effect, with significant pain reduction that held up over long-term follow-up. Glucosamine combined with ibuprofen also performed well. Chondroitin sulfate on its own receives a conditional recommendation for hand osteoarthritis specifically, so location matters. If you’re considering supplements, glucosamine plus omega-3 has the strongest current support, though the overall quality of evidence is moderate.
Rheumatoid Arthritis: A Different Approach
Rheumatoid arthritis is an autoimmune disease where the immune system attacks joint tissue, causing progressive damage. Pain relief alone isn’t enough. The goal is to suppress the underlying immune attack before it destroys joints permanently, which is why treatment centers on disease-modifying drugs rather than painkillers.
The standard first-line treatment is methotrexate, typically started alongside a short course of low-dose steroids to control symptoms while the methotrexate takes effect (it can take several weeks to reach full potency). If methotrexate doesn’t produce adequate improvement within three to six months, a biologic drug is added. Biologics are injectable or infused medications that block specific immune proteins driving joint inflammation.
If the first biologic doesn’t work well enough, switching to a different biologic (from the same or a different class) is the next step. This trial-and-adjustment process is normal and doesn’t mean treatment has failed. It means the disease is being narrowed down to the right target.
JAK Inhibitors: Powerful but With Caveats
JAK inhibitors are oral pills that block multiple inflammatory signals at once, offering an alternative to injectable biologics for rheumatoid arthritis. Four are currently approved for RA. They’re effective and convenient, but they carry specific safety concerns that have changed how they’re prescribed.
A large safety trial found that one JAK inhibitor was associated with higher rates of cardiovascular events and certain cancers compared to older biologic drugs. Regulatory agencies in both the U.S. and Europe responded by adding warnings to all drugs in this class. Current guidelines position JAK inhibitors as an option after careful consideration of individual risk, particularly in older patients and those with existing cardiovascular risk factors or a history of cancer. For younger, lower-risk patients, they remain a reasonable choice when biologics aren’t a good fit.
Choosing Based on Your Type and Situation
For knee or hip osteoarthritis, start with a topical anti-inflammatory gel. It matches oral pills for pain relief with a better safety profile. If that’s not enough, oral anti-inflammatory drugs are the next step, used at the lowest dose that controls your symptoms. Steroid injections can handle flare-ups. Adding omega-3 supplements alongside glucosamine may provide modest additional benefit.
For rheumatoid arthritis, methotrexate is the cornerstone. Most people tolerate it well, and it can slow or stop joint damage when started early. The key is getting on a disease-modifying drug quickly, since joint destruction in RA begins early and becomes irreversible. Anti-inflammatory drugs and steroids help with symptoms but don’t protect the joints themselves.
The “best” medication is ultimately the one that controls your specific disease with the fewest side effects for your health profile. Someone with knee osteoarthritis and heart disease needs a different strategy than someone with aggressive rheumatoid arthritis and no other health conditions. What the evidence makes clear is that effective options exist across the spectrum, and matching the treatment to the disease type is more important than any single drug choice.